MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K reports the results of an Extraordinary General Meeting of Shareholders held by MediWound Ltd. on February 19, 2026. The filing covers corporate governance actions rather than financial performance for a specific fiscal period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder voting outcomes.
Material Changes and Voting Results
Shareholders approved a proposal to increase the number of ordinary shares reserved for issuance under the Company's 2024 Share Incentive Plan by 300,000 shares. The voting details are as follows:
- Record Date: January 16, 2026
- Shares Outstanding: 12,815,094
- Shares Present (Quorum): 3,844,528 (approximately 30%)
- Votes in Favor: 3,490,863 (90.9%)
- Votes Against: 350,902 (9.1%)
- Abstentions: 2,763
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It serves solely to disclose the approval of the share plan amendment.
Key Facts for Investor Verification
- Shareholders approved an increase of 300,000 shares in the 2024 Share Incentive Plan.
- The proposal passed with 90.9% of votes cast in favor.
- Approximately 30% of outstanding shares were represented at the meeting.
- No financial performance data is included in this specific filing.